SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-306032
Filing Date
2023-12-29
Accepted
2023-12-29 17:29:00
Documents
16
Period of Report
2023-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d673597d8k.htm   iXBRL 8-K 30947
2 EX-1.1 d673597dex11.htm EX-1.1 196370
3 EX-5.1 d673597dex51.htm EX-5.1 9089
7 GRAPHIC g673597g1227233452928.jpg GRAPHIC 2424
8 GRAPHIC g673597g1227233453412.jpg GRAPHIC 1214
  Complete submission text file 0001193125-23-306032.txt   424105

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20231229.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20231229_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20231229_pre.xml EX-101.PRE 11266
10 EXTRACTED XBRL INSTANCE DOCUMENT d673597d8k_htm.xml XML 3363
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 231528715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)